BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 35720279)

  • 1. Clonal Distribution and Intratumor Heterogeneity of the TCR Repertoire in Papillary Thyroid Cancer With or Without Coexistent Hashimoto's Thyroiditis.
    Cui L; Zhang C; Ding H; Feng D; Huang H; Lu Z; Liu B
    Front Immunol; 2022; 13():821601. PubMed ID: 35720279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TCR repertoire intratumor heterogeneity of CD4
    Zhang C; Ding H; Huang H; Palashati H; Miao Y; Xiong H; Lu Z
    Int J Cancer; 2019 Feb; 144(4):818-827. PubMed ID: 30151844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-17A increases MHC class I expression and promotes T cell activation in papillary thyroid cancer patients with coexistent Hashimoto's thyroiditis.
    Han LT; Hu JQ; Ma B; Wen D; Zhang TT; Lu ZW; Wei WJ; Wang YL; Wang Y; Liao T; Ji QH
    Diagn Pathol; 2019 Jun; 14(1):52. PubMed ID: 31159823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T cell exhaustion is associated with the risk of papillary thyroid carcinoma and can be a predictive and sensitive biomarker for diagnosis.
    Zhu C; Dai Y; Zhang H; Ruan Y; Zhou Y; Dai Y; Fan L; Jia T; Lu H; Chen Q
    Diagn Pathol; 2021 Aug; 16(1):84. PubMed ID: 34465342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of
    Zhang Y; Xie X; Zhou H; Li B; Ding L; Cai Z; Song H; Zhao S; Xu H
    Front Endocrinol (Lausanne); 2023; 14():1131078. PubMed ID: 37455914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive analysis of lncRNA-mediated ceRNA regulatory networks and key genes associated with papillary thyroid cancer coexistent with Hashimoto's thyroiditis.
    Zhang Y; Tian Y
    BMC Endocr Disord; 2022 Oct; 22(1):252. PubMed ID: 36266640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Differential protein expressions in papillary thyroid carcinoma patients with or without Hashimoto's thyroiditis].
    Lu HZ; Zhang N; Liu W; Zhu XY; Qi D; Wang Y; Liu XY; Li ZJ
    Zhonghua Zhong Liu Za Zhi; 2020 Jun; 42(6):463-468. PubMed ID: 32575941
    [No Abstract]   [Full Text] [Related]  

  • 8. Impact of Hashimotoas thyroiditis on clinicopathologic features of papillary thyroid carcinoma associated with infiltration of tumor-infiltrating lymphocytes.
    Wang L; Li W; Ye H; Niu L
    Int J Clin Exp Pathol; 2018; 11(5):2768-2775. PubMed ID: 31938394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of regulatory T cells frequency in peripheral blood and tumor tissues in papillary thyroid carcinoma with and without Hashimoto's thyroiditis.
    Liu Y; Yun X; Gao M; Yu Y; Li X
    Clin Transl Oncol; 2015 Apr; 17(4):274-80. PubMed ID: 25387566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Impact of Coexistent Hashimoto's Thyroiditis on Central Compartment Lymph Node Metastasis in Papillary Thyroid Carcinoma.
    Liu Y; Lv H; Zhang S; Shi B; Sun Y
    Front Endocrinol (Lausanne); 2021; 12():772071. PubMed ID: 34867817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined effect of Hashimoto's thyroiditis and BRAF(V600E) mutation status on aggressiveness in papillary thyroid cancer.
    Kim SJ; Myong JP; Jee HG; Chai YJ; Choi JY; Min HS; Lee KE; Youn YK
    Head Neck; 2016 Jan; 38(1):95-101. PubMed ID: 25213729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of T cell receptor Vbeta diversity in peripheral CD4 and CD8 T lymphocytes in patients with autoimmune thyroid diseases.
    Okajima M; Wada T; Nishida M; Yokoyama T; Nakayama Y; Hashida Y; Shibata F; Tone Y; Ishizaki A; Shimizu M; Saito T; Ohta K; Toma T; Yachie A
    Clin Exp Immunol; 2009 Feb; 155(2):166-72. PubMed ID: 19040601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Warthin-like papillary thyroid carcinoma with immunoglobulin G4-positive plasma cells possibly related to Hashimoto's thyroiditis.
    Hirokawa M; Nishihara E; Takada N; Higuchi M; Kotakemori M; Hayashi T; Miyauchi A
    Endocr J; 2018 Feb; 65(2):175-180. PubMed ID: 29093307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identifying and analyzing the key genes shared by papillary thyroid carcinoma and Hashimoto's thyroiditis using bioinformatics methods.
    Liu TT; Yin DT; Wang N; Li N; Dong G; Peng MF
    Front Endocrinol (Lausanne); 2023; 14():1140094. PubMed ID: 37324256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Papillary thyroid carcinoma in children with Hashimoto's thyroiditis - a review of the literature between 2000 and 2020.
    Sur ML; Gaga R; Lazăr C; Lazea C; Aldea C; Sur D
    J Pediatr Endocrinol Metab; 2020 Dec; 33(12):1511-1517. PubMed ID: 33180046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Papillary thyroid cancer with Hashimoto's thyroiditis attenuates the tumour aggressiveness through the up-regulation of E-cadherin and TGF-β expression.
    Kim SJ; Lee SE; Kim YI; Nam-Goong IS; Jung HW; Kim ES
    Clin Exp Med; 2023 Jul; 23(3):833-840. PubMed ID: 35871446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioinformatics analysis identified shared differentially expressed genes as potential biomarkers for Hashimoto's thyroiditis-related papillary thyroid cancer.
    Liu C; Pan Y; Li Q; Zhang Y
    Int J Med Sci; 2021; 18(15):3478-3487. PubMed ID: 34522174
    [No Abstract]   [Full Text] [Related]  

  • 18. IL-10 Restores MHC Class I Expression and Interferes With Immunity in Papillary Thyroid Cancer With Hashimoto Thyroiditis.
    Lu ZW; Hu JQ; Liu WL; Wen D; Wei WJ; Wang YL; Wang Y; Liao T; Ji QH
    Endocrinology; 2020 Oct; 161(10):. PubMed ID: 32348468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hashimoto's Thyroiditis Does Not Affect Ultrasonographical, Cytological, and Histopathological Features in Patients with Papillary Thyroid Carcinoma.
    Baser H; Ozdemir D; Cuhaci N; Aydin C; Ersoy R; Kilicarslan A; Cakir B
    Endocr Pathol; 2015 Dec; 26(4):356-64. PubMed ID: 26481630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of T cell receptor repertoire in penile cancer.
    Zhang J; Wang Y; Huang Y; Tan X; Xu J; Yan Q; Tan J; Zhang Y; Zhang J; Ma Q; Zhu H; Ye J; Zhu Z; Lan W
    Cancer Immunol Immunother; 2024 Jan; 73(2):24. PubMed ID: 38280010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.